Course Outline
Click on the links below to preview selected pages from this course.
- Myeloproliferative Neoplasms
- Chronic Myeloid Leukemia
- Chronic Myeloid Leukemia (CML)
- CML and the Philadelphia Chromosome
- Laboratory Investigation of CML
- CML Peripheral Blood Smear
- Progression of CML
- Treatment of CML
- The Philadelphia chromosome, associated with chronic myeloid leukemia (CML), involves a reciprocal translocation of genes from which two chromosomes?
- Chronic Neutrophilic Leukemia
- Chronic Neutrophilic Leukemia (CNL)
- Chronic Neutrophilic Leukemia (CNL), continued
- Hypereosinophilic Syndrome/Chronic Eosinophilic Leukemia
- Hypereosinophilic Syndrome (HES)
- Chronic Eosinophilic Leukemia (CEL)
- What causes the characteristic heart and/or lung damage frequently demonstrated in patients with chronic eosinophilic leukemia?
- Essential Thrombocythemia
- Primary Myelofibrosis
- Primary Myelofibrosis (PMF)
- Diagnosis of Primary Myelofibrosis (PMF)
- Diagnosis of Primary Myelofibrosis: World Health Organization (WHO) Criteria
- Which of the following red blood cell morphologic features is associated with primary myelofibrosis?
- Polycythemia Vera
- Polycythemia Vera (PV)
- Diagnosis of Polycythemia Vera (PV)
- Treatment of Polycythemia Vera
- Which type of anemia can be caused by the common treatment for polycythemia vera, which is used to manage patient symptoms?
- Myeloproliferative Neoplasm, Unclassifiable (MPN-u)
- Summary
- References
Additional Information
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students and pathology residents.
Author information: Leah Coppolino, MPH, MLS(ASCP)CM is a Program Director at MediaLab, Inc. Previously, she was the Director of the Medical Laboratory Science Program at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. She holds a Masters in Public Health from Thomas Jefferson University.
Reviewer information: Rebecca J. Laudicina, PhD, MLS(ASCP)CM is Professor Emeritus in the Division of Clinical Laboratory Science at The University of North Carolina at Chapel Hill’s School of Medicine. She obtained a Master of Education and PhD in Educational Psychology from Temple University. She is the author of numerous hematology-related publications.
Reviewer information: Rory Huschka, M. Ed., MT(ASCP), has over 20 years of experience as a medical technologist, technical supervisor, professor, and manager. He is the former Director of Clinical Laboratory Science and Medical Laboratory Technician Programs at Brookline College. He is currently a Program Director at MediaLab, Inc. Rory holds a BS degree in Medical Technology from North Dakota State University and a Masters in Educational Leadership from Argosy University. He has also completed the Six Sigma Green Belt training at Villanova University.